The acting head of the Food and Drug Administration warned Tuesday that most people in the United States will contract COVID-19, as the country grapples with record levels of infections and hospitalizations.

"I think it's hard to process what's actually happening right now, which is most people are going to get COVID," Dr. Janet Woodcock, the acting commissioner of the FDA, said while testifying before the Senate Committee on Health, Education, Labor and Pensions on Capitol Hill in Washington, D.C. "What we need to do is make sure the hospitals can still function, [and] transportation, you know, other essential services are not disrupted while this happens."

New COVID-19 cases increased 55% worldwide in the week ending Jan. 9, the World Health Organization said on Tuesday.

More than 15 million new cases were reported, up from the about 9.5 million in the previous week, the United Nation's health agency said in its weekly epidemiological update. Omicron is "rapidly replacing" other variants of the virus, according to the update.

"In terms of disease severity, there is growing evidence that the Omicron variant is less severe as compared to other variants," the WHO said.

Last week's increase marked a slowdown from the 71% spike reported the previous week, following a "gradual" rise since October, according to the update.

Reported cases in the Americas increased 78%, down from a 100% increase the week prior. The greatest increase in new cases came in Southeast Asia, where newly reported cases increased 418%, the WHO said.

On average, the U.S. is now reporting more than 750,000 new COVID-19 cases per day, a more than sixfold increase compared to one month ago, according to federal data.

On Monday, the U.S. recorded a single-day high of more than 1.4 million new cases, following soaring demand for tests and a backlog of weekend reporting data.

The surging national case numbers may not be indicative of what is happening in every region of the country and the overall increase in the U.S. does not necessarily mean that some regions will not see a plateau or decline in numbers.

Although the incredibly high case totals are most certainly due, in large part, to the country's latest omicron surge, the data is incredibly volatile on a day-to-day level. Many states no longer report data over the weekends, which can create an illusion of very low totals on weekends and very high daily numbers on Mondays and Tuesdays.

Also, there was a major surge in demand over the holidays, which could artificially increase numbers. However, experts say overall totals are likely undercounted given the increased use of at-home COVID-19 testing.

-ABC News' Arielle Mitropoulos

In Los Angeles, the hard-hit Providence Cedars-Sinai Tarzana Medical Center is "in complete disaster mode," Dr. Eric Snyder, medical director of the emergency department, told ABC News.

The emergency room is overflowing, with 22 patients currently waiting for beds.

"These are patients who’ve been accepted by a doctor, but have no place to go," he said.

Snyder said the hospital is in far worse shape than at any point in the pandemic. Tents have been set up behind the hospital and a doctor is going patient to patient, hoping to send those home who don't need hospital care, he said.

“We are 100% broken," Snyder said.

-ABC News' Matt Gutman

Spain has reported more COVID-19 reinfections in a recent span of two weeks than it has during the rest of the pandemic, according to the latest data from a Spanish public health research institute.

Data from the Carlos III Health Institute shows there were 20,890 repeat infections reported in Spain from Dec. 22, 2021, to Jan. 5, 2022. That figure tops the 17,140 reinfections reported in the European country from the start of the pandemic in March 2020 to Dec. 22, 2021. The data includes confirmed, probable and possible cases.

Alfredo Corell, an immunology professor at Spain's University of Valladolid, told Spanish news site NIUS that the rising number of reinfections were due to the new and highly transmissible omicron variant.

"Prior to this variant, reinfections were anecdotal at the global level," Corell told NIUS. "Omicron has changed this paradigm."

In southern Africa, where the variant was first identified in November, preliminary research suggests that omicron is three times more likely to cause reinfections compared to other known variants of the virus, including the highly contagious delta. However, symptoms of reinfected individuals appear to be mild, according to Anne von Gottberg, a microbiologist at South Africa's National Institute for Communicable Diseases who is studying omicron.

"Previous infection used to protect against Delta," von Gottberg said during a press briefing on Dec. 2. "But now, with Omicron, that doesn't seem to be the case."